NUVL
Price
$78.24
Change
+$0.33 (+0.42%)
Updated
Jun 13 closing price
Capitalization
5.62B
53 days until earnings call
TVTX
Price
$14.50
Change
-$0.44 (-2.95%)
Updated
Jun 13 closing price
Capitalization
1.29B
47 days until earnings call
Interact to see
Advertisement

NUVL vs TVTX

Header iconNUVL vs TVTX Comparison
Open Charts NUVL vs TVTXBanner chart's image
Nuvalent
Price$78.24
Change+$0.33 (+0.42%)
Volume$364.27K
Capitalization5.62B
Travere Therapeutics
Price$14.50
Change-$0.44 (-2.95%)
Volume$1.58M
Capitalization1.29B
NUVL vs TVTX Comparison Chart
Loading...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVL vs. TVTX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVL is a Hold and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (NUVL: $78.24 vs. TVTX: $14.50)
Brand notoriety: NUVL and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVL: 65% vs. TVTX: 92%
Market capitalization -- NUVL: $5.62B vs. TVTX: $1.29B
NUVL [@Biotechnology] is valued at $5.62B. TVTX’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVL’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • NUVL’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 6 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • NUVL’s TA Score: 6 bullish, 3 bearish.
  • TVTX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than TVTX.

Price Growth

NUVL (@Biotechnology) experienced а +0.28% price change this week, while TVTX (@Biotechnology) price change was -5.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

NUVL is expected to report earnings on Aug 07, 2025.

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.62B) has a higher market cap than TVTX($1.29B). NUVL YTD gains are higher at: -0.051 vs. TVTX (-16.762). TVTX has higher annual earnings (EBITDA): -168.21M vs. NUVL (-322.59M). NUVL has more cash in the bank: 1.07B vs. TVTX (322M). TVTX has higher revenues than NUVL: TVTX (274M) vs NUVL (0).
NUVLTVTXNUVL / TVTX
Capitalization5.62B1.29B436%
EBITDA-322.59M-168.21M192%
Gain YTD-0.051-16.7620%
P/E RatioN/AN/A-
Revenue0274M-
Total Cash1.07B322M333%
Total DebtN/A400M-
FUNDAMENTALS RATINGS
TVTX: Fundamental Ratings
TVTX
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
41
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVLTVTX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 26 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOEX48.420.58
+1.22%
Global X Gold Explorers ETF
NVG11.78-0.07
-0.60%
Nuveen AMT-Free Municipal Credit Income Fund
NUDM34.67-0.46
-1.31%
Nuveen ESG Intl Dev Mkts Eq ETF
TPSC37.69-0.63
-1.65%
Timothy Plan US Small Cap Core ETF
FDHT20.22-0.46
-2.22%
Fidelity Digital Health ETF

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-2.95%
CRNX - TVTX
44%
Loosely correlated
-1.24%
XNCR - TVTX
42%
Loosely correlated
-2.55%
COGT - TVTX
41%
Loosely correlated
-1.94%
RLAY - TVTX
40%
Loosely correlated
-6.67%
NUVL - TVTX
39%
Loosely correlated
+0.42%
More